Final efficacy results from IMpower132: First-line atezolizumab plus chemotherapy in patients with stage IV non-squamous NSCLC Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Nishio, M.; Barlesi, F.; Ball, S.; Bordoni, R.; Cobo, M.; Dubray-Longeras, P.; Goldschmidt, J.; Novello, S.; Orlandi, F. J.; Sanborn, R.; Szalai, Z.; Ursol, G.; Mendus, D.; Wang, L.; Wen, X.; McCleland, M.; Hoang, T.; Phan, S.; Socinski, M.

Publication Date

  • November 1, 2020

webpage

published in

category

start page

  • S1386

end page

  • S1387

volume

  • 31